Insider filing · NAMS
NewAmsterdam Pharma Company N.V.
NAMS · Healthcare · 45 filings in 24 months
ticker →
Forbion Growth Management B.V. sold $11.7M of NewAmsterdam Pharma (NAMS)
Executed Dec 10 2024, disclosed Dec 12 2024, 2 days later.
Value, as filed
$11.7M
462,288 sh across 5 lots
Executed
Dec 10 2024
the trade date, as filed
Disclosed
Dec 12 2024
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
FV
Forbion Growth Management B.V.
10% owner
profile →
Forbion Growth Management B.V. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in NewAmsterdam Pharma Company N.V. (NAMS). The largest single filing was $11.7M of NAMS (462,288 sh across 5 lots, as filed), executed Dec 10 2024.
The name
NAMSHealthcare · NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with ca…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→